References
- J.DeitrickW.M.PruittWnt/β catenin-mediated signaling commonly altered in colorectal cancerProg Mol Biol Transl Sci1442016 49-6
- P.BoyleJ.S.LangmanABC of colorectal cancer: epidemiologyBMJ32172642000805808
- R.BendardafH.LamlumS.PyrhönenPrognostic and predictive molecular markers in colorectal carcinomaAnticancer Res244200425192530
- Proceedings of the First International Conference on the Clinical Uses of Carcinoembryonic Antigen. Cancer 1973; 42(3 Suppl): 1397–1659.
- D.M.GoldenbergA.M.NevilleA.C.CarterCEA, (carcinoembryonic antigen): its role as a marker in the management of cancerJ Cancer Res Clin Oncol10131981239242
- M.TurrizianiM.FantiniM.BenvenutoCarcinoembryonic antigen (CEA)-based cancer vaccines: recent patents and antitumor effects from experimental models to clinical trialsRecent Pat Anticancer Drug Discov732012265296
- R.E.HumbelInsulin-like growth factors I and IIEur J Biochem1901990445462
- D.LeRoithC.BondyS.YakarJ.L.LiuA.ButlerThe somatomedin hypothesisEndocr Rev2220015374
- G.WrobelP.RoerigF.KokocinskiMicroarray-based gene expression profiling of benign, atypical and anaplastic meningiomas identifies novel genes associated with meningioma progressionInt J Cancer1142005249256
- W.HartmannA.KochH.BruneInsulin-like growth factor II is involved in the proliferation control of medulloblastoma and its cerebellar precursor cellsAm J Pathol166200511531162
- C.M.PerksJ.M.HollyThe insulin-like growth factor (IGF) family and breast cancerBreast Dis1820034560
- C.M.PerksJ.M.HollyIGFBPs and breast cancerBreast Dis17200391104
- S.RajaramD.J.BaylinkS.MohanInsulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functionsEndocr Rev181997801831
- G.R.DeviD.H.YangR.G.RosenfeldY.OhDifferential effects of insulin-like growth factor (IGF)-binding protein-3 and its proteolytic fragments on ligand binding, cell surface association, and IGF-1 receptor signallingEndocrinol141141200041714179
- J.M.RicortInsulin-like growth factor binding protein (IGFBP) signallingGrowth Horm IGF Res142004277286
- S.A.RosenzweigWhat’s new in the IGF-binding proteins?Growth Horm IGF Res142004329336
- Anand P.ChokkalingamMichaelPollakCapri-MaraFillmoreInsulin-like growth factors and prostate cancer: a population-based case-control study in ChinaCancer Epidemiol, Biomarkers Prevention102001421427
- A.GrimbergP.CohenRole of insulin-like growth factors and their binding proteins in growth control and carcinogenesisJ Cellular Physiol183200019
- E.YılmazObez ve obez olmayan kadınlarda kardiyovasküler risk faktörleri ile insülin benzeri büyüme faktörü-1 ve insülin benzeri büyüme faktörü bağlayıcı protein 3 (igfbp3) arasındaki ilişki2009Tıpta Uzmanlık Teziİstanbul
- M.J.DuffyCEA as a marker for colorectal cancer: is it clinically usefulClin Chem472001624630
- R.BendardafH.LamlumS.PyrhonenPrognostic and predictive molecular markers in colorectal carcinomaAnticancer Res24200425192530
- G.M.JefferyB.E.HickeyP.HiderFollow-up strategies for patients treated for nonmetastatic colorectal cancer (Cochrane Review)The Cochrane Library Issue 22004John Wiley & Sons Ltd.Chichester (UK)
- J.J.SzymenrdaM.P.NowackiA.W.SzawlowskiJ.A.KaminskaPredictive value of plasma CEA levels: preoperative prognosis and postoperative monitoring of patients with colorectal carcinomaDis Colon Rectum2519824652
- M.J.DuffyaA.van DalencC.HaglunddTumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical useEur J Cancer43200713481360
- O.YılmazA.EroğluE.DağN.KaraoglanogluSerum levels of IGF-I and IGFBP-III and their relation with carcinoembryonic antigen and carbohydrate antigen 19–9 in cases of esophageal cancerInt J Clin Pract6012200616041608
- Rozlyn A.KrajcikNancy D.BorofskyStephenMassardoNormanOrentreichInsulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancerCancer Epidemiol, Biomarkers Prevention1111200215661573
- JingMaMichael N.PollakEdwardGiovannucciProspective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3J Natl Cancer Inst9171999
- R.J.TroisiA.N.FreedmanS.S.DevesaIncidence of colorectal carcinoma in the U.S.: an update of trends by gender, race, age, subsite, and stage, 1975–1994Cancer85199916701676
- R.C.BaxterInsulin-like growth factor binding proteins in the human circulation, a reviewHorm Res421994140144
- Y.OhH.L.MüllerH.PhamR.G.RosenfeldDemonstration of receptors for insulin-like growth factor binding protein-3 on Hs578T human breast cancer cellsJ Biol Chem26819932604526048
- R.RajahB.ValentisP.CohenInsulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-b1 on programmed cell death via a p53 – and IGF-independent mechanismJ Biol Chem27219971218112188
- R.G.MacDonaldB.S.SchafferI.J.KangS.M.HongE.J.KimJ.H.ParkGrowth inhibition and differentiation of the human colon carcinoma cell line, Caco-2, by constitutive expression of insulin like growth factor binding protein-3J Gastroenterol Hepatol1419997278
- James V.LaceyJr.NancyPotischmanM. PatriciaMadiganInsulin-like growth factors, insulin-like growth factor-binding proteins, and endometrial cancer in postmenopausal women: results from a U.S. Case-control studyCancer Epidemiol Biomarkers Prev1342004
- J.KhosraviA.DiamandiJ.MistryA.ScorilasInsulin-like growth factor I (IGF-I) and IGF-binding protein-3 in benign prostatic hyperplasia and prostate cancerJ Clin Endocrinol Metab28622001694699
- J.M.CulouscouM.Remacle-BonnetF.GarrousteJ.FantiniJ.MarvaldiG.PommierProduction of insulin-like-growth factor II (IGF-II) and different forms of IGF-binding proteins by HT-29 human colon cancer carcinoma cell lineJ Cell Physiol1431990405415
- G.PommierF.GarrousteF.el AtiqJ.MarvaldiM.Remacle-BonnetPotential role of IGFBPS in the regulation of the differentiation state of human colonic carcinoma cellsGrowth Regul3119938082
- H.QuanH.TangL.FangJ.BiY.LiuH.LiIGF1(CA)19 and IGFBP-3-202A/C gene polymorphism and cancer risk: a meta-analysisCell Biochem Biophys6912014169178
- R.LiuL.L.HuA.SunMRNA expression of IGF-1 and IGF-1R in patients with colorectal adenocarcinoma and type 2 diabetesArch Med Res4542014318324
- N.S.StanilovI.A.KarakolevT.S.DeliyskyJ.P.JovchevS.A.StanilovaAssociation of insulin-like growth factor-I receptor polymorphism with colorectal cancer developmentMol Biol Rep412201480998106
- B.JiangX.ZhangL.L.DuPossible roles of insulin, IGF-1 and IGFBPs in initiation and progression of colorectal cancerWorld J Gastroenterol206201416081613